SHEARWATER GROUP PLC
SWG | IL
Overview
Corporate Details
- ISIN(s):
- GB00BKT6VH21
- LEI:
- 213800ZRUKUYDJLKD504
- Country:
- United Kingdom
- Address:
- 22 GREAT JAMES STREET, WC1N 3ES LONDON
- Website:
- https://www.shearwatergroup.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Shield Therapeutics PLC is a patient-focused pharmaceutical company dedicated to improving the lives of those with iron deficiency. Our lead product, ACCRUFeR, offers a novel oral therapy for adults. We are committed to innovation in this critical area of unmet medical need.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-11 10:40 |
Directors' Dealings
Notification of major holdings
|
English | 42.2 KB | |
| 2025-07-10 11:00 |
Directors' Dealings
Grant of LTIP Options
|
English | 29.2 KB | |
| 2025-07-09 08:00 |
Earnings Release
FY25 Trading Update
|
English | 14.0 KB | |
| 2025-05-29 17:17 |
Directors' Dealings
Notification of major holdings
|
English | 42.2 KB | |
| 2025-05-28 08:00 |
Regulatory News Service
SWG company achieves landmark AI Certification
|
English | 13.7 KB | |
| 2025-02-19 16:56 |
Transaction in Own Shares
Director dealing
|
English | 35.4 KB | |
| 2025-02-17 15:32 |
Transaction in Own Shares
Director/PDMR Shareholding
|
English | 18.6 KB | |
| 2025-01-30 08:00 |
Directors' Dealings
Change of Year End and Grant of LTIP options
|
English | 28.2 KB | |
| 2024-12-20 08:00 |
Regulatory News Service
£2.3m Contract wins
|
English | 14.0 KB | |
| 2024-11-26 08:00 |
Earnings Release
Interim Results
|
English | 358.6 KB | |
| 2024-11-20 08:00 |
Investor Presentation
Notice of Investor Presentation
|
English | 14.2 KB | |
| 2024-11-07 08:00 |
Regulatory News Service
Contract Wins and Notice of Results
|
English | 14.7 KB | |
| 2024-09-25 16:59 |
Board/Management Change
Board Update
|
English | 11.8 KB | |
| 2024-09-24 16:47 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 11.1 KB | |
| 2024-08-29 18:42 |
Report Publication Announcement
Notice of AGM and Posting of Annual Report
|
English | 11.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
ABIVAX | France | ABVX | |
|
Addex Therapeutics Ltd | Switzerland | ADXN | |
|
AegirBio AB | Sweden | AEGIR | |
|
AGRONOMICS LIMITED | Isle of Man | ANIC | |
|
AIREA PLC | United Kingdom | AIEA | |
|
Alkaloid AD | North Macedonia | ALK | |
| Alma Yesodot Ltd. | Israel | KVSR | ||
|
Amphastar Pharmaceuticals Inc. | United States of America | AMPH | |
| Ananda Pharma Plc | United Kingdom | N/A | ||
|
Antibiotice S.A. | Romania | ATB |